S-Space

Browse

Subject

Showing results 1 to 4 of 4

Issue Date	Title / Author(s) / Citation	File
2013-10	Health-related quality-of-life assessment in CLEOPATRA, a phase III study combining pertuzumab with trastuzumab and docetaxel in metastatic breast cancer Cortes, J.; Baselga, J.; Im, Y. -H.; Im, S. -A.; Pivot, X.; Ross, G.; Clark, E.; Knott, A.; Swain, S. M. Annals of Oncology, Vol.24 No.10, pp.2630-2635	DOI
2014-08	A phase IIa dose-finding and safety study of first-line pertuzumab in combination with trastuzumab, capecitabine and cisplatin in patients with HER2-positive advanced gastric cancer Kang, Y-K; Rha, S. Y.; Tassone, P.; Barriuso, J.; Yu, R.; Szado, T.; Garg, A.; Bang, Y-J British Journal of Cancer, Vol.111 No.4, pp.660-666	DOI
2016-02	Pertuzumab in gastrointestinal cancer Oh, Do-Youn; Bang, Yung-Jue Expert Opinion on Biological Therapy, Vol.16 No.2, pp.243-253	DOI
2019-09	Pharmacokinetics of pertuzumab administered concurrently with trastuzumab in Chinese patients with HER2-positive early breast cancer Luo, Yang; Li, Wei; Jiang, Zefei; Zhang, Qingyuan; Wang, Liwei; Mao, Yixiang; Tjan-Heijnen, Vivianne C. G.; Im, Seock-Ah; McConnell, Robin; Bejarano, Sara; Fumagalli, Debora; Bines, Jose; Wang, Bei; Garg, Amit; Kirschbrown, Whitney P.; Xu, Binghe Anti-Cancer Drugs, Vol.30 No.8, pp.866-872	DOI